Skip to main content
Log in

Hypophosphatasie

Seltene Erkrankung in der Zahnarztpraxis

  • Fortbildung
  • Published:
Der Freie Zahnarzt Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3
Abb. 4

Literatur

  1. Mornet E, Yvard A, Taillandier A et al (2011) A molecular-based estimation of the prevalence of hypophosphatasia in the European population. Ann Hum Genet 75:439-445

  2. Mornet E (2007) The tissue nonspecific alkaline phosphatase gene mutations database. http://www.sesep.uvsq.fr/Database.html. Zugegriffen 02. Nov. 2020

  3. Rathbun JC (1948) Hypophosphatasia; a new developmental anomaly. Am J Dis Child 75:822-831

  4. Sobel EH, Clark LC, Fox RP et al (1953) Rickets, deficiency of alkaline phosphatase activity and premature loss of teeth in childhood. Pediatrics 11:309-322

  5. Salles JP (2020) Hypophosphatasia: biological and clinical aspects, avenues for therapy. Clin Biochem Rev 41:13-27

  6. Okawa R, Nakano K, Matsumoto M et al (2012) Oral manifestations of patients with hypophosphatasia. Pediatr Dent J 22:155-162

  7. Hennings R, Roth A, Seefried L (2015) Hypophosphatasie. In: Osteologie, S 200-207

  8. Hollis A, Arundel P, High A, Balmer R (2013) Current concepts in hypophosphatasia: case report and literature review. Int J Paediatr Dent 23:153-159

  9. Whyte MP, Leung E, Wilcox WR et al (2019) Natural history of perinatal and infantile hypophosphatasia: a retrospective study. J Pediatr 209:116-124.e4

  10. Högler W, Langman C, Gomes da Silva H et al (2019) Diagnostic delay is common among patients with hypophosphatasia: initial findings from a longitudinal, prospective, global registry. BMC Musculoskelet Disord 20:80

  11. Seefried L, Baumann J, Hemsley S et al (2017) Efficacy of anti-sclerostin monoclonal antibody BPS804 in adult patients with hypophosphatasia. J Clin Invest 127:2148-2158

  12. Hofmann C, Seefried L, Jakob F (2016) Asfotase alfa: enzyme replacement for the treatment of bone disease in hypophosphatasia. Drugs Today (Barc) 52:271-285

  13. Whyte MP, Greenberg CR, Salman NJ et al (2012) Enzyme-replacement therapy in life-threatening hypophosphatasia. N Engl J Med 366:904-913

  14. Whyte MP, Madson KL, Phillips D et al (2016) Asfotase alfa therapy for children with hypophosphatasia. JCI Insight. DOI 10.1172/jci.insight.85971

  15. Whyte MP, Rockman-Greenberg C, Ozono K et al (2016) Asfotase alfa treatment improves survival for perinatal and infantile hypophosphatasia. J Clin Endocrinol Metab 101:334-342

  16. McKee MD, Nakano Y, Masica DL et al (2011) Enzyme replacement therapy prevents dental defects in a model of hypophosphatasia. J Dent Res 90:470-476

  17. Schilke R, Schlagenhauf U (2018) Odontohypophosphatasie. Thieme-Refresher Zahnheilkd 10:1-16

  18. Hofmann C, Girschick HJ, Mentrup B et al (2013) Clinical aspects of hypophosphatasia: an update. Clin Rev Bone Miner Metab11:60-70

  19. Harks I, Koch R, Eickholz P et al (2015) Is progression of periodontitis relevantly influenced by systemic antibiotics? A clinical randomized trial. J Clin Periodontol 42:832-842

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Peggy Stölzel.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Heß, J., Stölzel, P. Hypophosphatasie. DFZ 65, 52–57 (2021). https://doi.org/10.1007/s12614-020-9479-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12614-020-9479-3

Navigation